Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.

Suppr

超能文献

作者信息

Ito T, Ogawa K, Sakai K, Watanabe J, Satake T, Kayama N, Hiraku S, Naito J

出版信息

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:245-51.

PMID:6221531

Abstract

摘要

相似文献

Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:245-51.

Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.

Circulation. 1984 Oct;70(4):599-605. doi: 10.1161/01.cir.70.4.599.

Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.

Adv Prostaglandin Thromboxane Leukot Res. 1985;13:375-7.

Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:371-6.

Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.

J Pharmacol Exp Ther. 1982 Aug;222(2):441-6.

Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:241-4.

Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:953-7.

Selective thromboxane synthetase inhibitor and ischemic heart disease.

Biomed Biochim Acta. 1984;43(8-9):S125-32.

The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.

Stroke. 1985 Mar-Apr;16(2):241-4. doi: 10.1161/01.str.16.2.241.

Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.

Prostaglandins Leukot Med. 1983 Sep;12(1):49-52. doi: 10.1016/0262-1746(83)90066-5.

引用本文的文献

Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.

J Clin Invest. 1983 Oct;72(4):1336-43. doi: 10.1172/JCI111089.

Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.

Proc Natl Acad Sci U S A. 1985 Jan;82(1):193-7. doi: 10.1073/pnas.82.1.193.

Actions of the novel thromboxane A2 antagonists, ONO-1270 and ONO-3708, on smooth muscle cells of the guinea-pig basilar artery.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):468-74. doi: 10.1007/BF00569388.

Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects.

Thorax. 1986 Dec;41(12):955-9. doi: 10.1136/thx.41.12.955.

Current issues in thrombosis prevention with antiplatelet drugs.

Drugs. 1986 Jun;31(6):517-49. doi: 10.2165/00003495-198631060-00004.

Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.

Br J Pharmacol. 1989 Feb;96(2):395-405. doi: 10.1111/j.1476-5381.1989.tb11830.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验